Preparation of 212Pb labeled monoclonal antibodies
Abstract:
The present invention relates to the generation of lead-212 for therapeutic use. Specifically, are methods related to the generation of lead-212 based radio labelled proteins, such as radioimmunoconjugates, embodiments of the present invention.
Public/Granted literature
Information query
Patent Agency Ranking
0/0